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INTRODUCTION 
The problem of urinary tract calculi has received 
attention in the form of salicylate therapy. This type of 
therapy was introduced by Prien and Walkers· and is based on 
the fact that salicylates are partly excreted by being con-
jugated with glucuronic acid to form glucuronosides. The 
authors, cited, have obtained good clinical evidence for 
inhibition of stone growth under aspirin therapy. Abrams,1 
however, in a study of 3 patients with no concurrent labora-
tory studies of calcium or glucuronide excretion, showed an 
increase in the size of the calculi of these patients under 
aspirin therapy for as long a period as 4 months. 
Does the glucuronide conjugate of acetylsalicylic 
* acid actually increase the dissolution of urinary calculi? 
Previous laboratory studies3~10 have shown glucuronides (a con-
centrate of mixed urinary glucuronides, or o-aminophenol 
glucuronide) to increase the dissolution of t ·.r:i •.calcium 
phosphate. Tricalcium·phosphate, however, is not a major 
or even common component of urinary calculi. Vermeulen et 
al~8 have shown that feeding aspirin or isoborneol to rats 
* See Figure 1, p. 16. 
2 
with surgically introduced artificial stone nidi of zinc 
showed no differences in the weight of stones formed at the 
end of 6 weeks. However, the aspirin treated rats in con-
trast to those receiving isoborneol produced no significant 
rise in urinary glucuronides during this period. Experi-
ments using menthol glucuronide were performed in the test 
tube and as with other workers showed increasing solubility 
of calcium and phosphorus, but here too, the precipitate was 
probably not hydroxy apatite, the major calcium phosphate 
compound in urinary calculi. In an experiment designed to 
test for complex formation, menthol glucuronide and calcium 
were dialysed against distilled water as were citrate and 
calcium. A 1 per cent glucuronide solution and a 0.1 per 
cent citrate solution retained about 20 per cent of the 
calcium in two hours. This might indicate the possibility 
of complex formation between calcium and the glucuronide. 
The purpose of this investigation was to demonstrate 
the effect of a glucuronide of salicylates on the dissolu-
tion of urinary calculi and their major component compounds. 
The diffuse pharmacological action of salicylates makes 
critical, in vitro experiments imperative. The ether gluc-
uronide conjugate of salicylic acid, o-carboxyphenyl-jB-D-
* glucopyranosiduronic acid (o-CPG), a known metabolic 
* See Figure 1, p. 16. 
product of salicylates found in urin~0 and stones of known 
composition or synthetic components of stones should be 
used in these experiments. 
3 
In the course of experiments in this investigation 
evidence of increased dissolution warranted further experi-
mentation into the possible cause of such effects. 
HISTORY 
Aspirin Therapy and Clinical Results 
In a study of 19 chronic stone formers observed over 
a period ranging from 12 to 14 months under a dosage of 2 gm 
of powdered aspirin each day, Prien and Walke~9 found no new 
growth of stones, nor increase in the size or density of 
existing stones in 17 of these patients. Of the two remain-
ing patient~ .one did not respond to the salicylate therapy 
with the expected glucuronide excretory product and the 
other, although responding as expected in this respect was 
found to have (after an 18 months period of observation) 
acid calcium phosphate stones, CaHPo4 • In the latter sub-
ject the calculi already present grew larger and new stones 
made their appearance; in the former there was slight growth 
of existing stones. (Although about 85 per cent of all 
urinary calculi contain calcium only 1.9 per cent .are of 
the acid calcium phosphate type.)17 The study involved a 
small number of patients and was carried out over a relatively 
short period of time~ However, the results were exceedingly 
in favor of an extended investigation. 
The Biochemical Basis for Therapx 
This therapy as initiated by Prien and Walker de-
rived from the qualitative experiments of Neuberg, Mandl 
and Grauer33 , 29 , 30 • In these experiments the authors at-
tempted to either dissolve calcium salts or to inhibit 
their precipitation by addition of naturally occuring or-
ganic and inorganic acids. They showed that 1-menthol-D-
glucuronic acid solubilizes both calcium carbonate and 
calcium phosphate salts, that it functions in this way 
5 
much better than non conjugated glucuronic acid and 'that in-
cubation of such a solubized mixture with)3-glucuronidase 
leads to precipitation of the salt. However, their experi-
ment used concentrations which were greater than ordinarily 
found in urine, even in urine of patients receiving sali-
cylates. 
The work of Cessi10 followed, in which the solubil-
izing effect of a glucuronide was observed during the syn-
thesis of the glucuronide by an !a vitro biological system. 
Rat liver slices were incubated at 38°C. in a modified 
Ringer's solution together with a solid phase of tricalcium 
phosphate containing radioactive phosphorus. o-Aminophenol 
was added to some of the experimental flasks. This was 
metabolized to the glucuronide conjugate at the rate of 0.3 
pg/mg tissu~/hr. The P32 appearing in the supernatant 
6 
showed clearly when compared with very adequate controls, 
that the solubility of the calcium phosphate increased, 
corresponding directly to the rise of the glucuronide con-
jugate as measured experimentally. The results also showed 
a later decline in solubilized phosphate even though the 
concentration of o-aminophenol glucuronide continued to 
rise, i.e. there appeared to be an optimal concentration 
of the glucuronide for maximal dissolution effect. This 
might be a reversal of either the accumulation of metabolic 
products or, as the author suggests, may be due to the pos-
sibility that the tissue having used up its own reserve 
supply of phosphate may have used the radioactive phosphate 
of solution for the synthesis of organic phosphate esters. 
He also demonstrated the occurence of an optimal glucuronide 
concentration in a control which contained no tissue, but 
which had the glucuronide added to it. This observation is 
unexplained and from the control experiment must be depend-
ent only on the glucuronide concentration and the nature of 
the calcium salt. 
Pharmacological Properties of Salicylates 
The mechanism of glucuronide formation as a "De-
toxication excretory product'' for salicylates is well docu-
mented. Like phenols, salicylates are excreted by the body, 
in part, as the glucuronide conjugate. Kapp and Coburn25 
found that humans excreted about 50 per cent of a 50mg/Kg 
dose of sodium salicylate in the first 24 hours. Of this 
amount about 25 per cent was excreted as free salicylic 
acid, 50 per cent as salicyluric acid and about 25 per cent 
as the conjugated glucuronide. 
7 
In later experiments Alpen et al. 2 using carboxylic-
labeled c14 salicylic acid demonstrated an excretion of 
10 - 85 per cent as salicylic acid, 0 - 50 per cent as 
salicyluri,c acid and 15· - 40 per cent as the glucuronide 
conjugate. However, their conjugate was pointed out to be 
probably consisting of both an ether and an ester glucuronide. 
Further confirmation of the existence of both forms 
of the conjugation is demonstrated in an excellent paper 
by Schachter. 40 After the ingestion of sodium salicylate 
by human subjects, approximately 50 per cent was found to 
be excreted in the urine in 24 hours and of this amount 
60 per cent appeared as the glycine conjugate while 30 per 
cent was excreted in equal amounts each of salicyl acyl 
glucuronide and salicyl phenolic glucuronide (SPG)*. The 
ester form which he finds is demonstrated to be a mono-
glucuronide. Teague46 in a review of D-glucuronic** acid 
* o-carboxyphenyl-)9-D-glucopyranosiduronic acid (o-CPG). 
**see Figure 1, p. 16. 
• 
8 
conjugates points out that p-hydroxybenzoic acid can be ex-
creted as the diglucuronide conjugate and only mentions 
salicylic acid as a possibility in this respect. 
Pharmacological studies of salicylates by Smith42 
have also shown the distinct probability that acetylsali-
cylic acid is hydrolyzed in plasma to salicylic acid 
* (o-hydroxybenzoic acid ) • The further metabolism of the 
salicylate to the glucuronide conjugate could then occur. 
An increase of urinary glucuronides .could then be 
made to occur by the ingestion of various "glucurogenins11 
(Teague). Prien and Walker39 have reported an increase of. 
200 to 400 per cent over the basal level of urinary gluc-
uronides in man during a 2 gm dose of aspirin/day. 
Intermediary Metabolism of Glucuronide Conjugates 
The intermediary metabolism of such compounds has 
been reviewed by Teague46 and more recently by Kalckar and 
Maxwe11. 24 
In vitro experiments by Dutton and Storey15 showed 
that rat liver homogenates in contrast to liver slices did 
not significantly conjugate glucuronic acid. At about the 
26 same time, Leloir described a coenzyme, uridine diphosphate 
* See Figure 1, p. 16. 
glucose (UD~S), isolated from Saccaramyces fragilis by 
8' . Caputto, Leloir et al. , as uridine-5'-phosphate coupled 
to glucose-1-phosphate (G-1-P) by a pyrophosphate linkage 
and utilized in the reversible conversion of G-1-P to 
galactose-1-phosphate (Gal-1-PO. Smith and Mills4l sug-
gested that a uridine diphosphate glucuronic acid (UDPGA) 
may possibly be synthesized from UDPG and not from a 
similar 2 step reaction as postulated for UDPG: 
(1) ATP + UDP ~ UTP + ADP 
(2) UTP + G-1-P ~ UDPG + P-P . 5 
Dutton and Storey16 found that their previously 
inactive rat liver homogenates could .be activated to syn-
thesize glucuronides by the addition of an acetone powder 
9 
of boiled liver extract. They concluded that~-glucuroni­
dase, the hydrolyzing enzyme for most glucuronides, was not 
involved in the synthesis, that the synthesis of a-amino-
phenyl glucuronides (in this case) was not affected by 
anaerobic conditions, cyanide, bicarbonate, or sulfate and 
that the transferring enzyme was in the cytoplasmic particu-
lates. It is also interesting to note that they found cal-
cium to be very inhibitory to the system. Isolation and 
characterization of this boiled liver factor (Storey and 
Dutton43), confirmed its resemblance to the UDPG of Caputto 
et al. ·8 and showed it to be UDPGA. The theoretical reaction 
~ 
I 
10 
presented was: 
UDPGA + Glucurogenin(R-OH) ---~ 
UDP + R-0-Glucuronide 
This transferring activity was shown to be present in liver 
and kidney slices. Their investigation clearly showed the 
cofactor to be UDP linked to glucuronic acid - 1 - phosphate 
44 by a pyrophosphate linkage. Strominger et al . c · demon-
strated that animal liver, particle-free, supernatant frac-
tions could oxidize UDPG to UDPGA if DPN+ were added to 
the system. The formation of o-aminophenol glucuronides 
required the transferring enzyme found in the microsomes. 
+ In 1957 the work was extended by purifying the DPN requir-
ing dehydrogenase. The reaction is irreversible: 
UDPG + 2DPN + UDPGA + 2DPNH + 2H + .45 
The glucuronides thus far examined for th~ir meta-
bolic pathways were of the ether type linkage originating 
from phenols. In 1955 Duttoni4 showed that p-aminobenzoic 
acid was metabolized to p-aminobenzoyl glucuronide with an 
ester type linkage, under the same conditions as those re~ 
quired for ether type conjugates. The finding that benzoate 
inhibited the synthesis of o-aminophenol glucuronide when 
o-aminophenol was the original glucurogenin, suggested the 
same enzyme to be involved. 
The Metabolic Fate of Glucuronic Acid 
The role of ingested glucuronic acid in this meta-
bolic scheme seems to be negligible. In 1952, Ormsby36 
investigated the possibility of man's ability to oxidize 
glucuronic acid. The results confirmed the work of 
Fishman et a1. 20 , that of a 5 gm dose of glucuronic acid 
lactone fed to adult males, only 15 - 20 per cent could 
be recovered in the urine and that the normal basal level 
of glucuronic acid in urine is about 400 - 700 mg/24 
hours. 
11 
Douglas and King13 examined the metabolism of 
uniformly labeled glucurone-c14 in guinea pigs and in the 
albino rat. The results were compatible with an hypothesis 
of glucurone cleaving to two three-carbon fragments. These 
three-carbon fragments could condense to a six carbon compound 
through the action of an aldolase and an isomerase which then 
goes into the formation of a glucuronide. Furthermore glu-
cose isolated from the glycogen of rats fed glucurone-6-c14 
showed the same specific activity in c6 as the glucuronic 
acid found in the urine. The results clearly indicated that 
a three-carbon fragment was utilized, but not as the im-
mediate precursor. ·contrary to these results, Eisenberg 
et a1. 18 feeding glucuronolactone-6-c13 or sodium gluc-
uronate-6-c13 along with 1-menthol to humans found no 
12 
· labeling in the "6" position of urinary glucuronides. 
Previously, Eisenberg19 had fed glucose-1-c14 to 
rabbits using menthol as the glucurogenin and found the 
glucuronide produced was highly labeled on c1 , but the mid-
dle four carbons were symmetrically labeled. He concluded 
that glucose or a six-carbon intermediate was the precursor 
of the glucuronic acid. Similarly, Doerschuk, 12 feeding 
guinea pigs, dl-borneol and glycerol-1-c14 concluded that 
. . 
glucuronide is a result of a condensation of three-carbon 
intermediates, and that glucose itself is not the intermediate. 
The three-carbon fragment as a contributor to the 
. 17 
formed glucuronides was demonstrated using lactate-3-c14• The 
resulting distribution of 6-c14 and of l-c14 in the urinary 
glucuronic acid and in glucose obtained from the glycogen of 
these guinea pigs showed the direct role of glucose or a 
glucose-like hexose as a precursor of glucuronic acid. 
Further confirmation that glucuronic acid is not 
utilized as such in the anabolism of glucuronides was shown 
by Butler and Packham, 7 who found after feeding naphthol 
glucuronide to rats that it was largely excreted unchanged, 
that glucuronic acid is relatively inert metabolically and 
that 50 per cent of glucuronolactone given by intraperitoneal 
injection is excreted as glucuronic acid, while about 50 per 
cent, similarly to glucose enters the metabolic scheme and 
13 
is metabolized to co2 and converted to glucuronide conjugates. 
The body tissues which can conjugate glucuronid~s 
have been studied by Hartiala2l in the rat, guinea pig, cat, 
dog, and rabbit. All species showed good 'conjugating abil-
ity in the liver and the kidney and the mucous membrane of 
the alimentary tract except the cat. 
Recently, work on inositol metabolism by Charalampous 
and Lyras11 has shown that this compound, Whose physiological 
action has not yet been elucidated, can be converted to 
glucuronic acid by the kidney. The significance of this 
observation in the above metabolic scheme is not known. 
Urinary Tract Calculi 
Urinary tract calculi have been shown by Prien37 · to 
contain calcium in 90 per cent of 1000 calculi studied. 
Thirty-three per cent were pure calcium oxalate, 3.4 per 
cent pure hydroxy apatite and 34 per cent were mixtures of 
calcium oxalate and hydroxy apatite. The remaining calcium 
containing stones were calcium hydrogen phosphate, mentioned 
earlier, and stones with mixtures of magnesium ammonium 
phosphate with hydroxy apatite and calcium oxalate or with 
hydroxy apatite alone. 
Hydroxy Apatite 
Hydroxy apatite is the crystal analogy of fluor-
34 
apatite. · ·· The detailed structure of fluorapatite has 
been well worked out by x-ray diffraction and the unit 
cell was found by Naray-Szab'o to be composed of 
ca10 (P04) 6F2 • ·. 9. In the case of hydroxy apatite then, 
hydroxyl groups simply are substituted for the flouride. 
Hydroxy apatite is considered to be the main inorganic 
4 . 
crystalline component of animal bone. · Apatite, as the 
general term for crystal structures of the type just des-
cribed, is the most common phosphate crystal found in 
urinary calculi. It may be hydroxy or carbonate apatite, 
and is identified by x-ray diffraction studies or petro-
14 
.hi • .as grap c m1croscopy. It is this component of urinary cal-
culi with which this investigation is mainly concerned. 
EXPERIMENTAL 
Studies on the Dissolution of Urinary Stones 
The first series of experiments was designed to 
find the effect of o-CPG on the dissolution of a urinary 
tract stone composed chiefly of hydroxy apatite. The ex-
periment was followed with phosphate determinations, using 
the colorometric procedure of Fiske and Subbarrow21 and 
measuring the absorption with a Coleman Jr. Spectropho-
tometer at 660 mp. Calibrated pyrex test tubes were used 
as cuvettes. 
Ingestion of salicylates leads to the excretion of · 
o-carboxyphenyl-~-D-glucopyranosiduronic acid · (o-CPG~ sali-
cylic acid, and salicyluric acid as noted before. The drug 
is known to increase the excretion of uric acid so in this 
experiment o-CPG, salicylic acid, salicyluric acid, uric 
*- ** acid and glucuronolactone _. were all examined for their dis-
solutive effect. One-tenth mMoles of each substance in 
question were placed in 10 inch x 1 inch dialysis tubing 
along with 4 - 5 glass beads, 100 mg of . the powdered urinary 
* See Figure 1, p. 16. 
** See Figure 2, p. 20. 
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stone and 10 ml of buffer. The bag was tied and placed in 
a 50 ml E:r lenmeyer flask containing 5-10 glass beads, 30 ml 
of the buffer and two drops of toluene to stop bacterial 
growth. The purpose of using dialysis tubing is to elim-
inate any centrifuging or filtering as part of the analysis 
procedure. Many times the filtering leads to small analytical 
errors and in the case of hydroxy apatite it is very diffi-
cult to remove the finely divided solid from the sample. 
This method is taken from the procedure of Levinskas2·1l and 
also Nordin. SS The buffer used was Michaelis universal 
veronal buffer at a pH of 7.8. Although barbital is a known 
complexer of calcium, Neuman and Neuman34 find that they may 
use sodium diethylbarbiturate buffer at .OOlM strength with 
solutions as concentrated as 0.001 M with respect to calcium 
with less than a one per cent error due to the low formation 
constant of the diethylbarbiturate complex with calcium. In 
our experiment, the diethylbarbiturate concentration was 
0.0029 M and the powdered stone, if it were 100 per cent 
hydroxy apatite by weight and entirely dissolved would re-
sult in a calcium concentration of 0.025 M. The small 
solubility of hydroxy apatite would reduce this concentration 
by at least a factor of 10. Furthermore it is felt that since 
the buffer is employed in the control flask as well as the 
unknowns that the chelating effect of the buffer is not a 
.... 
18 
significant factor in the experiment. The pH of 7. 8 was 
chosen because Prien and Walker39 in their laboratory 
studies of concentrated mixed urinary glucuronides find 
that varying the pH shows 7.8 to be optimal for the dis-
solutive effect. The flasks were placed in a shaking, con-
o stant temperature water bath kept at 38 c. At 5 hours and 
10 hours a 1 ml aliquot was removed from the external phase 
of each of the stoppered flasks and after diluting it 1:5 
with more of the buffer, analyzed for phosphorus. Duplicate 
flasks were set up for each substance in question and the 
control and duplicate analyses were performed on each flask. 
Synthesis of o-CPG 
The o-carboxyphenyl~-D-glucopyranosiduronic (o-CPG) 
acid was synthesized in this laboratory from glucuronolac-
tone (Corn Products Refining Co., New York, N.Y.) using the 
method of Lunsford and Murphey. 28 The methyl ester os 1-bromo-
2,3,4-triacetylglucuronic acid was first prepared by the 
method of Goebel and Babers22 found :Ina publication of the sup-
plier of the glucuronolactone. 3 Four hundred grams of glue~ 
uronolactone in 3 liters of alkaline methanol were concen-
trated to a syrup in vacuo and immediately acetylated in 
pyridine. The resulting crystals of ~-and)l-tetraacetyl­
glucuronic acid methyl ester were filtered off and washed 
19 
with alcohol-ether; m.p., 164- l77°C. One hundred grams 
of the methyl tetraacetylglucuronate were then dissolved in 
30 - 32 per cent hydrogen bromide in glacial acetic acid. 
This mixture was allowed to stand 5 - 24 hours at room temper-
ature and was then concentrated to a syrup in vacuo. The 
syrup was dissolved in chloroform, washed with saturated 
sodium bicarbonate solution and with water. After drying 
the chloroform layer over anhydrous sodium sulfate, it was 
concentrated ~ vacuo almost to dryness, dissolved in warm 
ethanol, crystallized and washed with cold ethanol. Recrys-
tallization using calcium carbonate and norit yielded a clean 
product with a melting point of l04°C. 
Twelve grams of the l-bromo-2,3,4-triacetylglucuronic 
acid methyl ester were ground with 9.1 gm methyl salicylate 
and 15 ml isoquinoline in a mortar surrounded by an ice bath. 
Freshly prepared and dry silver oxide was added slowly. After 
thorough mixing the mixture was allowed to stand for two 
hours in a dessicator and then extracted with ether.- The 
ether extract was washed with water and dried over sodium 
sulfate, concentrated ~ vacuo, extracted with petroleum 
ether (which was then discarded) • The residual oil was then 
dried in vacuo, dissolved in 95 pe~ cent ethanol and crystal-
lized by the addition of ice and water. Several recrystal-
lizations resulted in a fluffy, white, crystalline, yield of 
) 
.. - .. -
Figure 2. Synthesis of o-CPG. 
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Methyl-0-(2,3,4, triacetyl methyl 
ester D-glucopyranoside)-Salicylate 
Ba(OH) 
2 
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0-Carboxypheny 1- ,._D- gl ucopy rano-
siduronic acid (0-CPG) 
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methyl-o-(2,3,4-triacetyl methyl ester D-glucopyranosido) -
salicylate; m.p., 111°- 112°C. This compound gave negative 
Fehling's and ferric chloride tests indicating that no reduc-
ing sugar nor phenol were present. After heating with 6N 
HCl a positive ferric chloride test was obtained. · 
Three grams of this compound was hydrolyzed by barium 
hydroxide in the presence of ether for 16 hours at room 
temperature. The barium was later removed with co2 and 
after concentrating the solution to 100 ml in vacuo any ex-
cess barium still present was precipitated as the sulfate 
through the addition of sulfuric acid. The filtered solution 
was concentrated to dryness and the gummy melt remaining was 
triturated with ethyl acetate and ether. The precipitate 
formed was amorphous. It was washed several times with ace-
tone and benzene and evaporated to dryness. Final drying was 
carried out in an Abderhalden pistol and the melting point of 
this final product, o-carboxyphenyl,B-D-glucopyranosiduronic 
acid was 145-146°C. with decomposition. 
Salicyluric acid was kindly supplied by Dr. W. Foye, 
Massachusetts College of Pharmacy. 
The stone used for the experiment was supplied by 
Dr. E: L. Prien and was characterized by him as an apatite 
stone with a few crystals of magnesium ammonium phosphate 
between layers. 
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At the end of the first 5 hrs. the flasks contain-
ing o-CPG showed an 85 per cent increase in P over the con-
trols while in the flasks containing other compounds no in-
crease in dissolution could be demonstrated (See ~able 1). 
Table 2 shows the results at the end of 10 hrs. of incuba-
tion. The control flasks have increased in the concentra-
tion of phosphorus and the percentage increase of the others 
remains about the same with the exception of the flasks con-
taining o-CPG. The percentage increase over the controls is 
now only 36 per cent. This might indicate the o-CPG to be 
merely hastening the equilibration of the system. 
Studies on the Dissolution of Synthetic Hydroxy Apatite 
As stated above the stone used contained some 
crystals of magnesium ammonium phosphate and thus, synthetic 
hydroxy apatite was used in place of a stone : in the next 
experiment. The hydroxy apatite was synthesized in this 
6 ... 
laboratory using the method of Brasseur. . . Dr. E. L. Prien 
kindly examined the product ·:with t.he petrographic microscope· 
and found it to be apparently pure hydroxy apatite. In this 
experiment the effect of another glucuronide, the conjugate 
of estradiol is observed. The sample of this material was 
provided by Dr. H. Wotiz. The results at the end of 5.75 
hours of. incubation (See Table 3) show an increase in 
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TABLE 1. DISSOLUTION STUDIES OF HYDROXY APATITE FROM A 
POWDERED URINARY STONE AFTER 5 HOURS* 
Avg. P Avg. P I),H Per Cent 
SAMPLE O.D. mg/ml n:M:ileiml Before After · of 
(10-2) (10-4) Control 
Blank 0.0044 0.0 o.o 7.8 7.5 
Control o. 357 7.8 8.1 
ffl 0.357 7.8 8.1 
Control 0.325 7.8 8.1 
ff:2 0.321 2.75 8.88 7.8 8.1 100.0 
S.A. o. 362 7.8 7.8 
ffol 0.362 7.8 7.8 
S.A. 0.362 7.8 7.3 
ffo2 o. 362 2.90 9. 36 7.8 7.3 105.4 
G.L 0.387 7.8 7.9 
1fol o. 390 7.8 7.9 
G.L. 0.288 7.8 7.9 
#fo2 o. 310 2.75 8.88 7.8 7.9 100.0 
o-CPG 0.638 7.8 7.8 
.fj:l 0.624 7.8 7.8 
o-CPG 0.638 5.10 16.46 7.8 7.8 185.4 
1fo2 
U.A. 0.374 7.8 7.8 
1fl o. 374 7.8 7.8 
U.A. o. 337 7.8 7.7 
412 0.335 2.85 9.20 7.8 7.7 103.6 
SU.A. 0.420 7.8 7.6 
ffo l 0.414 7.8 7.6 
SU.A o. 347 7.8 7.8 
ffo2 0.337 3.05 9.85 7.8 7.8 110.9 
*Incubated in a shaking water bath at 38°C. 
Control: powdered stone (100 mg) 
S.A.: powdered stone (100 mg) and 0.1 mMoles Salicylic 
Acid 
G.L.: powdered stone (100 mg) and 0.1 mMoles glucuron-
olactone 
o-CPG: powdered stone (100 mg) and 0.1 mMoles o-carboxy-
phenyl-~-D-glucopyranosiduronic acid 
U.A.: powdered stone (100 mg) and 0.1 mMoles Uric Acid 
SU.A.: powdered stone (100 mg) and 0.1 mMoles Salicyl-
Uric Acid 
' 
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TABLE 2. DISSOLUTION STUDIES OF HYDROXY APATITE FROM A 
POWDERED URINARY STONE AFTER 10 HOURs* 
Av,. P Avg. P ' pH Per Cent 
SAMPLE o.o. mg ml utbles/ml Before After of (10-2) (10-4) Control 
Black 0.0044 0.00 0.00 7.8 7.9 
Control 0.469 7.8 8.0 
tfl 0.465 7.8 8.0 
Control 0.465 7.8 8.0 
ff:2 0.453 3.75 12.10 7.8 8.0 100.0 
s.A. 0.456 7.8 7.9 
111 0.456 7.8 7.9 
S.A. 0.453 7.8 7.2 
112 0.465 3.70 11.94 7.8 7.2 98.7 
GL 0.469 7.8 7.8 
1il 0.462 7.8 7.8 
GL 0.409 7.8 7.8 
1!2 o. 395 3.50 11.30 7.8 7.8 93.4 
o-CPG 0.658 7.8 7.7 
111 0.653 7.8 7.7 
o-CPG 0.598 7.8 7.8 
112 0.602 5.10 16.46 7.8 7.8 136.0 . 
U.A. 0.447 7.8 7.9 
1Fl 0.447 I 7.8 7.9 
U.A. 0.420 7.8 7.9 
1!2 0.429 3.50 11.94 7.8 7.9 98.7 
SU.A. 0.534 7.8 7.9 
1f:l 0.534 7.8 7.9 
SU.A 0.447 7.8 7.9 
1/:2 0.441 3. 95 12.75 7.8 7.9 105.4 
*Incubated in a shaking water bath at 38°C. 
Control: powdered urinary stone (100 mg) 
S.A.: powdered urinary stone (100 mg) and 0.1 mMoles 
Salicylic acid 
G.L.: powdered urinary stone (100 mg) and 0.1 mMoles 
glucuronolactone 
o-CPG: powdered urinary stone (100 mg) and 0.1 mMoles 
o-carboxyphenyl-fi-D-glucopyranosiduronic acid 
U .A.: powdered urinary stone (100 mg) and 0.1 mMoles 
uric acid 
SU.A.: powdered urinary stone (100 mg) and 0.1 mMoles 
salicyluric acid 
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TABLE 3. DISSOLUTION STUDIES OF SYNTHETIC HYDROXY APATITE 
. * AFTER 5. 7 5 HOURS 
I \ Per Cent Av,.P Avg.P I PH SAMPLE O.D. mg ml nMoles/rril of 
(10-3) (10-5) Before After Control 
Blank 0.0022 0.00 0.00 
Control 0.1163 7.8 8.0 
111 0.1163 7.8 8.0 
Control 0.1107 7.8 8.0 
112 0.1093 1.21 3.91 7.8 8.0 100.0 
o-CPG 0.668 7.8 7.8 
1fol 0.673 7.8 7.8 
o-CPG 0.796 7.8 7.8 
112 0.796 7.94 25.63 7.8 7.8 655.5 
E.G. 0.2147 7.8 8.0 
111 0.2147 7.8 8.0 
E.G. 0.2076 7.8 8.0 
112 0.2076 2.27 7.33 7.8 8.0 187.5 
*Incubated in a shaking water bath at 38°C. 
Control: powdered synthetic hydroxy apatite (100 mg) 
o-CPG: powdered synthetic hydroxy apatite (100 mg) and 
0.1 mMoles o-carboxyphenyl-~-D-glucopyranosid­
uronic acid 
E.G.: powdered synthetic hydroxy apatite (100 mg) and 
0.1 mMoles estradiol glucuronoside 
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dissolution of phosphorus of 555 per cent in the case of 
o-GPG and 87 per cent in the case of estradiol glucuronoside. 
The large increase in dissolution in the case of 
hydroxy apatite compared with the hydroxy apatite containing 
urinary stone may possibly be due to a masking of the effect 
in the latter instance by magnesium ammonium phosphate. 
Inspection of Tables 1 and 3 reveals that the concentration 
of the control phosphorus for the calculus is, indeed, 
greater than the control phosphorus of the synthetic hydroxy 
apatite. However, thetncrement of test over control in 
mMoles P/ml for the calculus is only 7.58 while for the syn-
thetic hydroxy apatite it is 21.72. If there is a masking 
due to the magnesium ammonium phosphate, it is not the only, 
or major factor causing the disparity. 
It seemed fairly clear that o-CPG increased the dis-
solution of urinary calculi (those with apatite) and pure 
hydroxy apatite. The pH of the test solutions in the above 
experiments remained fairly constant. 
Studies on Complex Formation 
The first possible explanation for these results, 
which occured to us was that o-CPG was complexing calcium 
ion and this mechanism increased the dissolution of the 
hydroxy apatite. Although there are several methods for the 
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detection of ·Complexation of metals by organic anions (see 
Martell and Calvin·31), the use of conductivity was chosen 
because of its sensitivity at low concentrations. 
Conductometric Titrations 
A typical conductometric titration is carried out 
as follows: the solution of the organic compound to be 
tested is placed in a beaker and titrated with sodium 
hydroxide while measuring the electrical resistance. A 
plot of specific conductance or reciprocal ohms against mEq. 
of base added usually shows a steady negative slope to a 
minimal point of neutrality followed by a rising positive 
slope. This is due to the fact that the hydrogen ions of 
solution (of very fast mobility) are being neutralized by 
the hydroxyl ions of the added base. After neutrality has 
been reached the added hydroxyl ions also of high mobility 
raise the conductivity again. The organic acid solution is 
now titrated with the base of the metal in question (in our 
case calcium). In many complex formations the sequestration 
of the metall±c ion may result in the production of highly 
mobile ions as in the case of ethylenediaminetetraacetic . 
acid and a titration curve will result which differs from 
the curve of a non-complexed base. The curve will maintain 
the usual type of negative slope until a pH is reached at 
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which point complexation may begin to take place. When an 
ion such as calcium is complexed by ethylenediaminetetraacetic 
acid hydrogen ions are released into solution. These hydro-
gen ions then neutralize hydroxyl ions which have accompanied 
each atom of metal. The addition of a metallic hydroxide to 
an organic acid which will form a poorly dissociated complex 
with the cation produces very little change in conductivity 
from that of the organic anion alone. Thus, a conductivity 
plateau exists until no more calcium is complexed. Then the 
conductivity will rise as previously described as more base 
is added. 
The titrations were carried out in a 30 ml beaker 
using a motor-driven glass stirrer. Platinum titration 
electrodes already surfaced with platinum black, with a sur-
face area of about 1 cm2 were purchased from a laboratory 
supply house. The electrodes were rigidly supported in a 
permanent position and lowered into the titration beaker. 
Conductivities were measured with a Leeds Northrop null 
point galvanometer Wheatstone bridge, powered with 110-120 
v. A.C. from the house line being fed through a 117 V. volt-
age regulator. The titrations were carried out at room 
temperature, using a 10 ml microburette to deliver the solu-
tion. All solutions were prepared in triple distilled water. 
The cell constant was determined using 0.01 N KCl and found 
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to be 0.701. 
Tables 4 and 5 and Figure 4 show the results of the 
titration of glucuronolactone with 0.0098 N sodium hydroxide. 
The titration with calcium hydroxide was carried out 24 hours 
following the titration with sodium hydroxide. It is thought 
that during this time further equilibration takes place 
between D-glucuronolactone and the acid form, D-glucuronic 
acid. This would account for the higher position of the 
calcium hydroxide titration curve along the ordinate. 
This also is probably the explanation of the differ-
ence in the neutralization point. The diverging slopes of 
the two curves after the neutralization may be an indication 
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of complex formation. · If complex formation exists here, 
it is not strong, and the complex is more stable in basic 
solution. However, the results here are not definitive due 
to the arbitrary character of the curve. 
The results of a titration of salicylic acid with the 
two bases can be seen in Tables 6 and 7 and Figure 3-. The . 
graphs of both curves are almost identical or superimposable 
and there is no evidence here to conclude that a complex is 
being formed. It is important to bear in mind that this type 
of evidence when positive is meaningful but when negative 
merely indicates no production of highly mobile or conducting 
ions and therefore does not completely rule out the pos-
sibility of complex formation. 
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TABLE 4. CONDUCTCMETRIC TITRATION OF 5 ml. OF GLUCURON-
OLACTONE (O.tM) WITH SODIUM HYDROXIDE (0.0098 N) 
AT ROOM TEMPERATURE 
m1 mEq. 
1* Di1u-
L* . 
NaOH NaOH Ohms tion * · cor-
added add~d 
(104) (10-4) 
factor rected (10- ) (10-5) 
0.0 0.00 0.338 2.96 1.00 2 . 1 0.1 0.98 0. 370 2.70 1.02 1.9 0.2 1.96 0.405 2.47 1.04 1.8 0 . 3 2.94 0.450 2.22 1.06 1.7 0.4 3.92 0.470 2.13 1.08 1.6 0.5 4.90 0.500 2.00 1.10 1.5 0.6 5.88 0.510 1.96 1.12 1.5 0 . 7 6.86 0.540 1.85 1.14 1.5 0.8 7.84 0.525 1.90 1.16 1.5 0.9 8.82 0.562 1.78 1.18 1.5 1.0 9.80 0.535 1.87 1.20 1.6 1.1 10.78 0.550 1.82 1.22 1.6 1.2 11.76 0.530 1.89 1.24 1.6 1.3 12.74 0.558 1.79 1.26 1.6 
1.4 13.72 0.570 1.75 1.28 1.6 
1.5 14.70 0.510 1.96 1.30 1.8 
1.6 15.68 0.480 2.08 1.32 1.9 
1.7 16.66 0.440 2.27 1.34 2.1 
1.8 17.64 0.440 2.27 1.36 2.2 
1.9 18.62 0.410 2.44 1. 38 2.4 
2.0 19.60 o. 385 2.60 1.40 2.6 
2.1 20.58 0.370 2.70 1.42 2.7 
2.2 21.56 o. 370 2.70 1.44 2.7 
2.3 22.54 0.-355 2.82 1.46 2.9 
2.5 24.50 0.335 2.99 1.50 3.1 
2.6 25.48 o. 330 3.03 1.52 3.2 
2.8 27.44 o. 310. 3.23 1.56 3.5 
3.0 29.40 0.290 3.45 1.60 3. 9 
3.2 31.36 0.290 3.45 1.64 4.0 
3.4 33.32 0.270 3.70 1.68 4.4 
3.6 35.28 0.255 3.92 1.72 4.7 
3.8 37.24 0.240 4.17 1. 76 ' 5.1 
4.0 39.20 0.260 3.85 1.80 4.9 
4.2 41.16 0.250 4.00 1.84 5.2 
4.4 43.12 0.235 4.26 1.88 5.6 
4-.6 45.08 0.230 4.35 1.92 5.9 
4.8 47.04 0.220 4.55 1.96 6.2 
5.0 49.00 0.210 4.76 2.00 6.7 
"K 1 : measured conductivity • ~ 
- onms 
L : specific conductance = 1 'f... k (k = cell constant) 
Dilution Factor: original volume + volume -added 
original volume 
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TABLE 5. CONDUCTOMETRIC TITRATION OF 5 m1. OF GLUCURON-
OLACTONE (0.1 M) WITH CALCIUM HYDROXIDE (0.0094N) 
AT ROOM TEMPERATURE 
' 
m1 mEq. L 
Ca(OH) 2 Ca(OH) 2 Ohms 1 Di1u- cor-added ad de~ 
(104) (10 -4) 
tion rected (1o- ) factor (10-5) 
0.0 o.oo 0.140 7.14 1.00 5.0 
0.1 0.94 0.149 6.71 1.02 4.8 
0.2 1.88 0.151 6.62 1.04 4.8 
0.3 2.82 0.158 6.33 1.06 4.7 
0.4 3.76 0.160 6.25 1.08 4.7 
0.5 4.70 0.166 6.02 1.10 4.6 
0.6 5.64 0.167 . 5.99 1.12 4.7 
0.7 6.58 0.167 5.99 1.14 4.8 
0.8 7.52 0.172 5.81 . 1.16 4.7 
0.9 8.46 0.178 5.62 1.18 4.6 
1.0 9.40 0.182 5.49 1.20 4.6 
1.2 11.28 0.188 5.32 1.24 4.6 
1.4 13.16 0.198 5.05 1.28 4.5 
1.6 15.04 0.212 4. 72 1.32 4.4 
1.8 16.92 0.215 4.65 1.36 4.4 
2.0 18.80 0.215 4.65 1.40 4.6 
2.2 20.68 0.215 4.65 1.44 4.7 
2.4 22.56 0.215 4.65 1.48 4.8 
2.6 24. 44 0.215 4.65 1.52 5.0 
2.8 26.32 0.213 4.69 1.56 5.1 
3.0 28.20 0.211 4. 74 1.60 5.3 
3.2 30.06 0.210 4.76 1.64 5.5 
3.4 31.96 0.208 4.81 1.68 5.7 
3.6 33.84 0.208 4.81 1.72 5.8 
3.8 35.72 0.205 4.88 1.76 6.0 
4.0 37.60 0.205 4.88 1.80 6.2 
4.2 39.48 0.200 5.00 1.84 6.4 
4.4 41.36 0.200 5.00 1.88 6.6 
4.6 43.24 0.200 5.00 .1.92 6.7 
5.0 47.00 0.192 5.21 2.00 7.3 
5.5 51.70 0.182 5.49 2.10 8 . 1 
6.0 56.40 0.174 5.75 2.20 8.9 
6.5 61.10 0.165 6.06 2. 30 9.8 
7.0 65.80 0.158 6.33 2.40 10.6 
7.5 70.50 0.155 6.45 2.50 11.3 
8.0 75.20 0.150 6.67 2.60 12.1 
8.5 79.90 0.146 6.85 2.70 13.0 
9.0 84.60 0.143 6.99 2.80 13.7 
9.5 89.30 0. 140 7.14 2.90 . 14.5 
10.0 94.00 .'0 ~ 138 7.24 3.00 15.2 
-.:t 
' 0 
~ 
-
0 4.0 8.0 
FIGURE 4 
CONDUCTOHETRIC TITRATION OF GLUCURONOLACTONE WITH 
SODIUM HYDROXIDE AND CALCIUM HYDROXIDE 
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TABLE 6. CONDUCTOMETRIC TITRATION OF 5 m1 OF SALICYLIC 
ACID (1.075 x 10-~) WITH SODIUM HYDROXIDE 
(1.075 x 10-~) AT ROOM TEMPERATURE 
m1 mEq Di1u- ' L 
NaOH NaOH Ohms 1 tion cor-
added added factor rected 
(10-3) (104) (10-4) (10-5) 
0.0 0.0 5.3 0.19 1.0 1.3 
0.1 0.108 7.5 0.13 1.02 0.9 
0.2 0.215 8.9 0.11 1.04 0.8 
0.3 0.323 7.7 0.13 1.06 0.9 
0.4 0.430 6.8 0.15 1.08 1.1 
0.5 0.538 6.0 0.17 1.10 1.3 
0.6 0.645 5.2 0 • .19 1.12 1.5 
0.8 0.860 4.05 0.25 1.16 2.0 
1.0 1.075 3.4 0.29 1.20 2.4 
.. ... 
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TABLE 7. CONDUCTOMETRIC TITRATION OF 5 m1. OF SALICYLIC 
ACID (1.075 x 10-4 M) WITH CALCIUM HYDROXIDE 
(1.075 x 10-3N) AT ROOM TEMPERATURE 
ml r mEq. Di1u- L 
Ca(OH) 2 Ca(OH) 2 Ohms 1 tion cor-
added added factor rected 
(10-3) (104) (10-4) (10-5) 
0.0 0.0 5.1 .0.20 1.00 1.4 
0.1 0.11 7.2 0.14 1.02 1.0 
0.2 0.22 7.8 0.13 1.04 0.9 
0.3 o. 32 ·-· 7. 3 0.14 1.06 1.0 
0.4 0.43 6.3 0.16 1.08 1.2 
0.5 0.54 5.5 0.18 1.10 1.4 
0.6 0.65 4.8 0.21 1.12 1.6 
0.8 0.86 3.9 0.26 1.16 2.1 
1.0 1.08 3.2 0.31 1.20 2.6 
1.2 1.29 2.8 o. 36 1.24 3.1 
1.4 1.51 2.5 0.40 1.28 3.6 
1.6 1. 72 2.2 0.46 1. 32 4.3 
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The conductometric titration of o-carboxyphenyl-fi-
D-glucopyranosiduronic acid with calcium hydroxide resulted 
in the typical curve of a strong acid neutralized with a 
strong base. (See Figure OJ It is almost identical with 
the curve for the sodium hydroxide titration. The slopes 
are not parallel, either before the neutralization nor just 
immediately after but the curves in general are so close 
as to conclude a negative answer to the question of complex 
formation. The t~tration data are presented in Tables 8 
and 9. 
TABLE 8. 
ml 
NaOH 
added 
o.o 
0.5 
1.0 
1.5 
2.0 
CONDUCTOMETRIC TITRATION OF 5 ml of o-CARBOXY-PHENYL-~-D GLUCOPYRANOSIDURONIC ACID (1.075xl0-~) 
WITH SODIUM HYDROXIDE (1.075xlO-~) AT ROOM 
TEMPERATURE 
mEq. Dilu- Lxl05 
·NaOH Ohms 1 tion cor-
added factor rected 
(10- 3) (104) . (10-4) (10-5) 
0.0 2.45 0.408 1.0 2.86 
0.538 4.35 0.230 1.1 1.77 
1.075 4.40 0.227 1.2 1.91 
1.613 3.00 0.333 1.3 3.03 
2.150 2. 30 0.435 1.4 4.27 
38 
TABLE 9. CONDUCTOMETRIC TITRATION- OF 5 m1 OF o-CARBOXY-
PHENYL-~-D-GLUCOPYRANOSIDURONIC ACID (1.075x10-~) 
WITH CALCIUM HYDROXIDE (1.075x10- 3N) AT ROOM 
· TEMPERA1URE 
m1 tnEq. I Di1u- I L Ca(OH) 2 Ca(OH) 2 Ohms 1 tion cor-
added added factor rected 
(10- 3) (10 4) (10 - 4) (10-5) 
0.0 0.0 2.45 0.408 1.0 2~86 
0.3 0.323 3.35 0.299 1.06 2.22 
0.4 0.430 3.60 0.278 1.08 2.10 
0.5 0.538 4.14 0.241 1.1 1.86 
0.6 0.645 4.35 0.230 1.12 1.81 
0.7 0.753 4.90 0.204 1.14 1.63 
0.8 0.860 4.90 0.204 1.16 1.66 
0.9 0.968 4.55 0.220 1.18 1.82 
1.0 1.075 4.40 0.227 1.20 1.91 
1.1 1.118 3.90 0.256 1.22 2.19 
1.3 1.398 3.48 0.287 1.26 2.54 
1.5 1.613 3.05 0.328 1. 30 . 2.99 
1.6 1. 720 2.90 0.345 1.32 3.19 
1.8 1.935 2.65 0.377 1. 36 3.60 
2.0 2.150 2. 38 0.420 1.40 4.12 
2.3 2.473 2.05 0.488 1.46 4.99 
2.5 2.688 1.90 0.526 1.50 5.54 
2.8 3.010 1.75 0.571 1.56 6.25 
3.0 3.225 1.71 0.585 1.60 6.56 
3.3 3.548 1.59 0.629 1.66 7.29 
3.5 3.763 1.50 0.667 1. 70 7.92 
4.0 4.300 1.30 0.769 1.80 9.67 
4.5 4.838 1.20 0.833 1.90 11.08 
5.0 5. 375 1.11 0.901 2.00 12.62 
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CONDUCTOMETRIC TITRATION OF o-CPG 
WITH SODIUM HYDROXIDE AND 
CALCIUM HYDROXIDE 
Ca(OH) 2 
" "' 
/ 
6"' , 
t" 
/ NaOII 
"' ,.,, 
/"' 
lA'' 
4.0 ·~ ·--... / ~ ...... ,...... ...... 
2.0 
0 1.0 2.0 
ml of 1.075 x 10-3 N base added 
"' 
"' 
,..'ll! 
1/ , 
3.0 
39 
40 
Variation of Conductivity with Concentration 
In a second type of conductivity experiment the 
conductance of calcium lactate was measured at varying 
dilutions. The same type of measurement was made on o-CPG 
alone and then the two compounds together each at one half 
the original concentration were measured at different dilu-
tions. If complexation occurs the mixed measurements 
should produce a series of conductivities either much higher 
or much lower than the calculated additive conductivity. 
The results may be seen in Table 10 and Figure 1. In this 
figure the conductivity of a solution of calcium lactate at 
decreasing concentrations is shown as well as a similar 
curve for o-CPG. The calculated conductivity is plotted 
in between these two curves and is calculated adding one 
half the value of each of the separate curves at any par-
ticular concentration. The conductivity curve of the mix-
ture is shown and is neither much higher nor much lower 
than the calculated conductivity. This would indicate no 
complex formation taking place. 
This method has an advantage over the titration 
method previously described. If, complex formation exists 
and no highly mobile ions result, then a decrease in con-
ductivity will be seen due to the sequestering of the cal-
cium ion and its virtual removal from participation in the 
TABLE 10. SPECIFIC CONDUCTIVITIES OF CALCIUM LACTATE AND o-CARBOXYPHENYL-)9-D• 
* GLUCOPYRANOSIDURONIC ACID IN WATER 
. . 
Concentration M/L 
(10-4) 
o-carboxyphenyl- Calcium Lactate 
Calcium )5-D-glucopyrano- and 
lactate siduronic acid o-carboxyphenyl-
(I) (II) 
)9-D-glucopyrano-
siduronic acid 
1.09 0.82 0.55 0.27 1.08 0.81 0.54 0.27 (I)0.55 0.41 0.27 0.14 
(II)0.54 0.40 0.27 0.13 
L 
(10-6) 31.1 26.8 20.3 12.4 50.8 43.3 30.4 ~5.8 39.2 31.3 23.6 12.8 
*conductivities measured at 38'C. 
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SPECIFIC CONDUCTIVITIES OF A MIXTURE OF o-CPG AND 
CALCIUM LACTATE COMPARED WITH THEORETICAL CONDUCTIVITIES 
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conductivity of the solution. Conversely, the release of 
hydrogen ions into solution by complex formation would raise 
the conductivity of the mixture. 
This experiment was repeated with calcium chloride 
in order to be sure that the observations were not produced 
by the weak dissociation of any lactic acid formed. The 
results in Table 11 and Figure 8 show the results which are 
in accord with those obtained with calcium lactate. 
Further Dissolution Studies of Synthetic 
Hydroxy Apatite 
This negative evidence is, however, concerned with 
the possible complexation of calcium ions by the o-CPG. It 
is necessary to consider_ the possible complexation of 
phosphate or of a calcium phosphate compound. The design 
·of an experiment to test these possibilities was essentially 
that of the previous dissolution studies. A control flask 
consisted of hydroxy apatite with an added amount of phos-
phate as a solution of monobasic potassium phosphate in the 
buffer used at pH 7.8. The test flask contained hydroxy 
apatite, with the addition of a solution containing o-CPG 
and phosphate which had been prev.iously incubating together 
at room temperature. The results in Table 12 show that the 
TABLE 11. SPECIFIC CONDUCTIVITIES OF CALCIUM CHLORIDE AND o-CARBOXYPHENYL-)3-D-
. * GLUCOPYRANOSIDURONIC ACID IN WATER 
Concentration M/L 
(10-4) 
o-Carboxyphenyl- Calcium chloride 
Calcium )5-D-glucopyrano- and 
chloride siduronic acid o-Carboxyphenyl-
(I) (II) 
p-D-glucopyrano-
siduronic acid 
1.08 0.81 0.54 0.27 1.08 0.81 0.54 0.27 (1)0.54 0.40 0.27 0.13 
(II)0.54 0.40 0.27 0.13 
L (1o-6) 38.1 29.3 22.3 13.7 59.4 46.7 34.2 18.0 45.3 35.8 25.0 12.5 
*conductivities measured at 38'C. 
0 .27 
FIGURE 8 
SPECIFIC CONDUCTIVITIES OF A MIXTURE OF o ·CPG AND 
CALCIUM CHLORITE COMPARED WITH THEORETICAL CONDUCTIVITIES 
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control flask at the end of 5 hours of incubation at 38°C. is 
not significantly higher in phosphate concentration than the 
hydroxy apatite control containing no phosphate. The test 
flask containing o-CPG and phosphate showed an increase of 
phosphate of 563 per cent which is not significantly differ-
ent from the control flask which contains only hydroxy apatite 
and o-CPG. Further it may be noted that its phosphate concen-
tration is higher than the o-CPG control by about 8 per cent. 
This is the . increase found in the hydroxy apatite-phosphate 
flask over the hydroxy apatite-on~y fla.sk. The conclusion 
is drawn that o-CPG does not c~lex phosphate. 
A second type of control flask was· .also prepared i~ 
which was plac.ed hy~oxy . apatite a~ before W,ith .the addi~ 
tion of barium ion -d phosphate ion• nese two ions are 
added as the aupe~atant solution. of an incubated mixture 
of barium ehlo_ride .·lUld monobasic potassium phosphate in 
. ;.. ' ,. . . . . 
the pH 7.8 buffer .. The test flaskc:onta:Lned hydrOlo/ apa ... 
tite with the addition of barium,. phosphate and . o-CPG. · In 
this case the o ... CfG .was .incubated lfith the , barium chioride; 
monoba~Jic potass~t.im phosphate solution and the .. sup~rnatant 
added to the flask as before. The results (see Table 12 . · 
. ·; . . ' . ' ~ : ' ' . . : ;. . 
~ ; 
s~ow . the control to be higher than tilt! hf:~oxy apati.te• 
only flask by th~ same insignificant amoun.t of phosp~te · 
as the · hydroxy ap:atite-phosphate eont'J';Ol . The test 
. . . ·.• 
fl~sk showed a significant decrea,~e in the dissolution of 
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TABLE 12. THE INFLUENCE OF P04 AND Ba + f ON THE INCREASED 
DISSOLUTION OF SYNTHETIC HYDROXY APATITE BY o-CPG* 
Av,. P Av,. P pH ·· Per Cent SAMPLE O.D. mg ml mM ml of 
(10- 3) (10-5) Before After Control 
BlANK 0.0022 0.0 0.0 
Control 0.1163 7.8 8.0 ffol 0.1163 7.8 8~0 Control 0.1107 7.8 8.0 1J:2 0.1093 1.21 3.91 7.8 8.0 100.0 
o-CPG 0.668 7.8 7.8 ffl 0.673 7.8 7.8 
o-CPG 0.796 7.8 7.8 ff2 0.796 7.94 25.63 7.8 7.8 655.5 Control 
plus P04 0.1192 7.8 8.0 
ffol 0.1192 7.8 8.0 Control 0.1249 7.8 7.6 
plus P04 0.1278 1.31 4.23 7.8 7.6 108.2 ff2 
Control 
plus Ba~~ 
and P04 0.1235 7.8 8.0 
ffl 0.1235 7.8 8.0 
Control+~ 
plus Ba 
and P04, 0.1249 7.8 8.1 
ff2 0.1249 1.32 4.26 7.8 8.1 109.0 
o-~PG plus 
0.870 7.8 po= 7.7 ~1 0.870 7.8 7.7 
o-QPG plus 0.569 7.8 7.8 po= 4 
ffo2 0.569 7.80 25.92 7.8 7.8 663.0 
o-CPG plus 
Ba+and po= 0.565 7.8 7.8 
Ill 4 0.569 7.8 7.8 
o-CPG plus 
Bat-and P04. 0.495 7.8 7.8 
fJ:2 0.491 5.73 18.5 7.8 7.8 473.1 
'I( 
Incubated in a shaking water bath at 38 'C. for 5 hours. _ 
Control: powdered synthetic hydroxy apatite (100 mg) 
o-CPG: powdered synthetic hydroxy apatite (100 mg) and 0.1 mM 
o-carboxyphenyl~-D-glucopyranosiduronic acid. 
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the hydrOXY apatite as .measured by phosphate concentration. 
The increase was only 373 per cent over the control compared 
to 555 per cent for the flask containing only hydroxy apatite 
and o-CPG 
The amounts and concentrations of the solutions 
added to determine if calcium and phosphate form a complex 
together are found in the following table. 
TABLE 13. CONCENTRATIONS OF SOLUTIONS INCUBATED AND ADDED 
TO HYDROXY . APATITE* 
/ i 
Flask ml of ml of mg ml Description 0.0026 0.0020 
mM/ml p mM/ml Ba o-CPG buffer 
Control plus P04 0.45 o.o 0.0 14.55 
-++ Control plus Ba 
0.45 1.0 0.0 13.55 and PO( 
1 -++ o-CPG p us Ba 
0.45 1.0 47.14 13.55 and P04 
*10 ml of the proper mixture is added to the dialysis bag 
-of the corresponding flask. 
This experiment would suggest then that barium, 
phosphate and o-CPG might be complexed together and the in-
hibition of hydroxy apatite dissolution by barium and 
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phosphate in turn suggests that a complex of calcium, phos-
phate and o-CPG may be formed. The formation of such a 
complex may explain the increased dissolution of hydroxy apa-
tite by o-CPG. 
DISCUSSION AND CONCLUSIONS 
o-Carboxyphenyl-;B-D-glucopyranosiduronic acid 
(o-CPG) a known metabolic product of salicylic acid found 
in urine has been shown to increase the dissolution of 
urinary calculi composed chiefly of hydroxy apatite. This 
conclusion was drawn from in vitro experiments using actual 
urinary stones and synthetic o-CPG. The amount of dissolu-
tion was determined by phosphate analysis. Synthetic 
hydroxy apatite also dissolved to a greater extent in the 
presence of o-CPG than in a buffered solution alone. There 
was a 5 fold greater increase in phosphate concentration 
using synthetic hydroxy apatite than with the urinary calculus. 
This was not entirely due to the presence of magnesium ammo-
nium phosphate in the stone. 
Conductometric titrations of o-CPG with sodium 
hydroxide and calcium hydroxide showed by the similarity 
of the plotted titration curves that calcium is probably 
not complexed by o-CPG. An experiment of this nature is 
not an absolute answer to the question of complex formation 
when the results are negative, since the formation of the 
complex may not release protons. 
Measurements were made of the conductivity of 
varying dilutions of a calcium salt solution and also of 
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a solution of o-CPG. A combined solution of both these 
compounds each at one-half the previous initial concentra-
tions resulted in a conductivity versus concentration 
curve which resembled the theoretical curve closely enough 
to conclude that complex formation was absent. This 
method would demonstrate not only the production of highly 
mobile ions. during formation of the complex, but also the 
simple sequestering of the metal and reduction of conductiv-
ity when no highly conductive ions are produced. The 
combined results of these two types of conductivity experi-
ment suggest that no complexation of calcium by o-CPG takes 
·.~ 
place. 
The effect of barium ions and phosphate ions on the 
dissolution of synthetic hydroxy apatite was tested in the 
same manner as the earlier experiments on dissolution. It 
was observed that previous incubation of the o-CPG with 
phosphate ions before addition to the hydroxy apatite pro-
duced no significant inhibition of the increased dissolution 
caused by o-CPG. Prior incubation with barium ions and 
phosphate ions however, resulted in a decrease of 30 per 
cent of the original dissolutive effect of o-CPG with 
hydroxy apatite. Since barium is a divalent cation which 
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has approximately the same association constant with poly-
phosphates as does calcium77 we interpreted this inhibition 
as being due to the formation of a complex of barium ion, 
phosphate ion and o-CPG. From this it follows that dissolu-
tion of hydroxy apatite is caused by complex formation 
between o-CPG, calcium ion and phosphate. 
We conclude that o-carboxyphenyl~-D-glucopyranosid­
uronic acid increases the dissolution of urinary tract 
calculi containing calcium phosphate in the form of hydroxy 
apatite. 
The inorganic structure of human bone is known to 
be hydroxy apatite4 and is the same as the inorganic struc-
ture of urinary tract calculi containing apatite. (In both 
instances the hydroxyl groups may be substituted for by 
other inorganic anions such a~ fluoride or carbonate ·. 9) 
When one considers the fact that considerable glucuronide 
synthesis takes place in the liver it becomes apparent, as 
20 the experimental work of Fishman et al. on the blood 
glucuronide content has shown, that the blood contains sig-
nificant amounts of glucuronides. We have shown the 
glucuronide of salicylic acid (o-CPG) to increase the dis-
solution of hydroxy apatite. We have also shown that 
estradiol glucuronide increases the dissolution of hydroxy 
apatite. In the light of these two observations, especi-
ally the latter since it is naturally occurnng in the 
human body, it is possible to speculate on the effect of 
the glucuronide in bone dynamics. The mobilization of 
calcium and the continuous process of bone resorption may 
be highly dependent on the concentrations of glucuronides 
in the blood. This is a very important question and 
should receive further attention. 
The work presented has suggested that calcium and 
phosphate may be complexed together by o-CPG. · Although 
this is not a proven fact it suggests that perhaps the 
glucuronide facilitates dissolution of hydroxy apatite 
53 
at the crystal surface of the apatite. The spatial arrange-
ment of the unit cell and arrangement of charged groups on 
the surface may provide attractive templates for certain 
glucuronides. Adsorption of the g~ucuronide to the surface 
of the crystal may in turn increase the escaping tendency 
of the component ions of the crystal latiee. An investiga-
tion in this direction should be carried out. 
Vermuelen et a1. 49 have shown that normal urine 
contains an unidentified substance which increases the 
dissolution of calcium phosphate in an unknown manner. 
Miller, Vermeulen and Moore32 then observed in an accompany-
ing paper concerned with calcium oxalate that supersatura-
tion of the urine with respect to this compound could be 
entirely explained by the effect of ionic strength. The 
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observation that an unidentified substance favors the dis-
solution of calcium phosphate but not calcium oxalate sup-
ports the suggestion presented in this investigation that 
calcium and phosphate are complexed together by o-CPG. It 
may also be evidence in favor of the speculation that 
o-CPG produces its dissolutive effect at the surface of 
the hydroxy apatite crystal. The effect of o-CPG on the 
dissolution of calcium oxalate should be examined. Further-
more, a repetition of Vermuelen's calcium phosphate studies 
using;s-glucuronidase should determine Whether the unknown 
factor in urine which increases the dissolution of calcium 
phosphate is a glucuronide. 
The evidence presented in this investigation 
corroborates the earlier rationale ~ollowed by Prien and 
Walker39 in initiating aspirin therapy for urinary calculi. 
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ABSTRACT 
Prien and Walker39 have treated chronic kidney 
stone formers with aspirin. They obtained clinical 
evidence showing no new stone growth and inhibition of 
the growth of existing stones. The rationale behind such 
therapy is that aspirin is excreted as a glucuronide con-
jugate in the urine, and the glucuronide increases dis-
solution of calcium phosphate stones. 
Previous laboratory studies39 , 10 have shown 
glucuronides (a concentrate of mixed urinary glucuronides, 
or o-aminophenol glucuronide) to increase the dissolution 
of tricalcium phosphate. Tricalcium phosphate is neither 
a major nor even common component of urinary calculi. 
The purpose of this investigation is to demonstrate 
the effect of a glucuronide of salicylates on the dissolu-
tion of urinary calculi and their major component compounds. 
The diffuse pharmacological action of s~licylates makes 
critical, in vitro experiments imperative. The ether 
glucuroniqe conjugate of salicylic acid, o-~~rboxyphenyl 
-;,8-D-glucopyranosiduronic acid (o-CPG), · a ·known metabolic 
. 40 
produ'?t of salicylates found in urine and stones of known 
composition or synthetic components of stones should be 
used in these experiments. 
In the course of this investigation evidence of 
increased dissolution warranted further experimentation 
into the possible cause of such effects. 
Aspirin therapy as initiated by Prien and Walker 
derived from the qualitative experiments of Neuberg, 
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Man~l and Grauer33 , 29 , 30 • In these experiments the authors 
attempted to either dissolve calcium salts or to inhibit 
their precipitation by addition of naturally occurring or-
ganic and inorganic acids. They showed that 1-menthol-D-
glucuronic acid solubilizes both calcium carbonate and 
calcium phosphate salts, that it functions in this way 
much better than non conjugated glucuronic acid and that 
incubation of such a mixture with~-glucuronidase leads 
to precipitation of the salt. 
The work of Cessi10 followed in which the solubil-
izing effect of a glucuronide was observed during the 
synthesis of the glucuronide by an in vitro biological 
P32 system. in the supernatant fluid resulting from dis-
solution of a solid phase of tricalcium phosphate contain-
ing p32 (placed in the flask with t~e liver slices) was 
measured by counting the activity. The increase of p32 
over a control flask was found to vary directly with the 
glucuronide concentration. 
Salicylates have been shown to be excreted as the 
phenolic glucuronide40 , 25 , 2 . Smith42 has shown that 
acetylsalicylic acid is probably hydrolyzed in plasma to 
form salicylic acid. 
An increase of urinary glucuronides could then be 
made to occur by the ingestion of various "glucurongenins" 
(Teague). Prien and Walker39 have reported an increase 
of 200 - 400 per cent over the basal level of urinary 
glucuronides in man during a 2 gm dose of aspirin I day. 
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Glucuronides are manufactured largely by the liver, 
. 15 23 24 kidney and mucosa of the al1mentary tract ' ' . The 
biosynthesis requires a coenzyme, uridine diphosphate which 
is thought to react with glucose to produce uridine 
diphosphoglucose which then may be oxidized to uridine 
diphosphoglucuronic acid in the presence of DPN + 45 • The 
uridine diphosphoglucuronic acid will then transfer the 
glucuronic acid to a proper acceptor such as a phenol. 
The role of ingested glucuronic acid in this meta-
bolic scheme seems to be negligible. Only a small percent-
age is recovered in the urine20 • Douglas and King using 
labeled glucurone found the glucuronic acid in the urine to 
be labeled in such a way as to support the theory that the 
glucurone breaks to three-carbon fragments. These fragments 
probably form a six-carbon precursor of glucuronic acid. 
64 
Urinary tract calculi have been shown by Prien37 
to contain calcium in 90 per cent of 1000 calculi ~tudied. 
Thirty-three per cent were pure calcium oxalate, 3.4 per 
cent pure hydroxy apatite and 34 per cent were mixtures 
of calcium oxalate and hydroxy apatite. 
Hydroxy apatite is considered to be the main inor-
ganic component of animal bone. The chemical structure of 
a unit cell is ca10 (P04) 6 (0H) 2 
34
'
9
'
4
• This crystal is the 
most common phosphate crystal found in urinary calculi. It 
is this component of urinary calculi with which this investi-
gation is mainly concerned. 
EXPERIMENTAL 
The first series of experiments were designed to 
find the effect of o-CPG on the dissolution of a urinary 
tract stone composed chiefly of hydroxy apatite. The degree 
of dissolution was followed with phosphate determinations, 
using the colorometric procedure of F:.i:llke- and Subbarow. 21 
Since uric acid, salicylic acid, salicyluric acid and 
o-CPG are all found in the urine in increased amounts fol-
lowing ingestion of salicylates, these compounds were ex-
amined for their dissolutive effect. 
The test flask contained 100 mg of a powdered 
urinary stone composed mainly of hydroxy apatite, and 0.1 
mMoles of the test compound. The mixture was placed in a 
' 
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small dialysis bag along with 4-5 glass beads and 10 ml of 
buffer. This bag was placed in a 50 ml Erlenmeyer flask 
containing 30 ml of the ·buffer and a few glass beads. 
Several drops of toluene were added to prevent bacterial 
contamination. The bufferuaad was Michaelis universal 
veronal buffer, pH 7.8. This pH was chosen because 
39 . . . 
Prien and Walker had found it to be optimal for dissolu-
tion of calcium phosphate in their early experiments. 
The o-CPG was synthesized in this laboratory using the 
method of Lunsford and Murphey. 28 
The flasks were placed in a shaking water bath at 
38°C. and aliquots of the external phase in the flasks . 
were analysed at 5 hours and 10 hours. Duplicate flasks 
were set up for each substance in question and for the 
control flask which contained hydroxy apatite only. 
At the end of 5 hours the o-CPG flask showed an 
increase in the phosphate concentration of 85 per cent 
over the control. The other substances showed little or 
no increase. After 10 hours the o-CPG showed an increase 
of 36 per cent over the control. We conclude that o-CPG 
· increases the dissolution of urinary tract calculi 
composed mainly of hydroxy apatite. Furthermore, it is 
suggested from the decreasing per cent of increased dis-
solution over time that the o-CPG also hastens the equi-
librium of dissolution. 
66 
The experiment was repeated substituting synthetic 
hydroxy apatite, prepared in this laboratory, for the 
powdered stone. Estradiol glucuronide was examined as 
well as o-CPG. After 5.75 hours both glucuronides in-
creased dissolution; the estradiol glucuronide increased 
the dissolution by 87 per cent and in this case the o-CPG 
produced a 555 per cent increase. It can be concluded 
that o-CPG increases dissolution of hydroxy apatite and 
that it werks better on pure hydroxy apatite than on 
other forms of calcium and phosphate. Other investigators39 ,l0 
have found an increase of about 40 per cent using calcium 
phosphate. 
The first possible explanation for these results, 
which occurred to us was that o-CPG was complexing calcium 
ion. In order to determine if complex formation with calcium 
were taking place, conductometric titrations were performed. 
The titration curves of sodium hydroxide and of calcium 
hydroxide with o-CPG, glucuronolactone and salicylic acid, 
were compared. If the sodium hydroxide titration fits well 
to the calcium hydroxide titration curve, one concludes 
that no highly conductive ions are produced and complex 
formation is absent. The results showed that there is a 
possibility that a slight amount of complex formation may 
have occurred with glucuronolactone but certainly not 
with salicylic acid or o-CPG. 
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Further proof that no complexing of calcium was 
taking place was obtained by measuring conductivity of 
separate solutions of calcium lactate and o~CPG at different 
concentrations. They were then combined, each at one half 
their original concentration and the resultant conductivity 
compared with the theoretical conductivity which we cal-
culated. Results show that the combined conductivity is 
about the same as the theoretical and therefore complex 
formation is absent. This type of experiment was repeated 
using calcium chloride instead of calcium lactate and the 
same results were obtained. The only conclusion we can 
draw is that o-CPG does not complex calcium. 
It was thought that perhaps o-CPG complexes calcium 
and phosphate together. To test this hypothesis another 
dissolution experiment was designed similar to the first 
ones reported. However, the o-CPG was incubated in one 
case with phosphate and in another case with barium and 
phosphate before being added to the synthetic hydroxy 
apatite. The only test flask which showed a significant 
difference from the controls was that one in which o-CPG 
was incubated first with barium and phosphate. Here, 
the dissolution effect of o-CPG was decreased by 30 per 
cent. We conclude that calcium and phosphate may be 
complexed together by o-CPG. 
In summary we may state that o-CPG increases the 
dissolution of urinary tract calculi containing hydroxy 
apatite; it increases the dissolution of synthetic 
hydroxy apatite; it does not form a complex with calcium 
but it may form a complex with calcium and phosphate. 
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The results also suggest that it may increase the dissolu-
tion of hydroxy apatite by acting at the surface of the 
crystal. This question requires further investigation • . 
